/Revvity%20Inc_%20logo%20on%20phone%20and%20site%20by-%20T_Schneier%20via%20Shutterstock.jpg)
Headquartered in Waltham, Massachusetts, Revvity, Inc. (RVTY) is a global provider of life sciences and diagnostics solutions with a market cap of $14.96 billion. Specializing in innovative products and services that advance scientific research, healthcare, and diagnostics, Revvity plays a crucial role in enhancing patient outcomes and supporting breakthroughs in medical science.
Shares of RVTY have underperformed the broader market considerably over the past year. RVTY has gained 4.3% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 27%. Also, in 2024, the stock is up 10.9%, compared to the SPX’s 18.1% rise on a YTD basis.